Searched for: in-biosketch:true
person:segevd01
PRE-TRANSPLANT FRAILTY IS A KEY DETERMINANT OF GLOBAL FUNCTIONAL HEALTH AFTER LIVER TRANSPLANTATION: FROM THE MULTICENTER FUNCTIONAL ASSESSMENT IN LIVER TRANSPLANTATION (FRAILT) STUDY [Meeting Abstract]
Lai, Jennifer Cindy; Shui, Amy; Rahimi, Robert S.; Ganger, Daniel R.; Verna, Elizabeth C.; Volk, Michael; Kappus, Matthew R.; Ladner, Daniela P.; Boyarsky, Brian J.; Segev, Dorry L.; Gao, Ying; Huang, Chiung-Yu; Singer, Jonathan; Duarte-Rojo, Andres
ISI:000707188004220
ISSN: 0270-9139
CID: 5133362
Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier
Boyarsky, Brian J; Strauss, Alexandra T; Segev, Dorry L
A wide gap between the increasing demand for organs and the limited supply leads to immeasurable loss of life each year. The organ shortage could be attenuated by donors with human immunodeficiency virus (HIV) or hepatitis C virus (HCV). The transplantation of organs from HIV+ deceased donors into HIV+ individuals (HIV D+ /R+) was initiated in South Africa in 2010; however, this practice was forbidden in the USA until the HIV Organ Policy Equity (HOPE) Act in 2013. HIV D+/R+ transplantation is now practiced in the USA as part of ongoing research studies, helping to reduce waiting times for all patients on the waitlist. The introduction of direct acting antivirals for HCV has revolutionized the utilization of donors with HCV for HCV-uninfected (HCV-) recipients. This is particularly relevant as the HCV donor pool has increased substantially in the context of the rise in deaths related to drug overdose from injection drug use. This article serves to review the current literature on using organs from donors with HIV or HCV.
PMID: 33471156
ISSN: 1432-2323
CID: 5126912
Implementing a Height-Based Rule for the Allocation of Pediatric Donor Livers to Adults: A Liver Simulated Allocation Model Study
Ge, Jin; Wood, Nicholas; Segev, Dorry; Lai, Jennifer C; Gentry, Sommer
PMCID:8273072
PMID: 33459499
ISSN: 1527-6473
CID: 5126902
Changes in Functional Status Among Kidney Transplant Recipients: Data From the Scientific Registry of Transplant Recipients
Chu, Nadia M; Chen, Xiaomeng; Bae, Sunjae; Brennan, Daniel C; Segev, Dorry L; McAdams-DeMarco, Mara A
BACKGROUND:With stressors of dialysis prekidney transplantation (KT) and restoration of kidney function post-KT, it is likely that KT recipients experience a decline in functional status while on the waitlist and improvements post-KT. METHODS:We leveraged 224 832 KT recipients from the national registry (SRTR, February 1990-May 2019) with measured Karnofsky Performance Status (KPS, 0%-100%) at listing, KT admission, and post-KT. We quantified the change in KPS from listing to KT using generalized linear models. We described post-KT KPS trajectories using adjusted mixed-effects models and tested whether those trajectories differed by age, sex, race, and diabetes status using a Wald test among all KT recipients. We then quantified risk adverse post-KT outcomes (mortality and all-cause graft loss [ACGL]) by preoperative KPS and time-varying KPS. RESULTS:Mean KPS declined from listing (83.7%) to admission (78.9%) (mean = 4.76%, 95% confidence interval [CI]: -4.82, -4.70). After adjustment, mean KPS improved post-KT (slope = 0.89%/y, 95% CI: 0.87, 0.91); younger, female, non-Black, and diabetic recipients experienced greater post-KT improvements (Pinteractions < 0.001). Lower KPS (per 10% decrease) at admission was associated with greater mortality (adjusted hazard ratio [aHR] = 1.11, 95% CI: 1.10, 1.11) and ACGL (aHR = 1.08, 95% CI: 1.08, 1.09) risk. Lower post-KT KPS (per 10% decrease; time-varying) were more strongly associated with mortality (aHR = 1.93, 95% CI: 1.92, 1.94) and ACGL (aHR = 1.84, 95% CI: 1.83, 1.85). CONCLUSIONS:Functional status declines pre-KT and improves post-KT in the national registry. Despite post-KT improvements, poorer functional status at KT and post-KT are associated with greater mortality and ACGL risk. Because of its dynamic nature, clinicians should repeatedly screen for lower functional status pre-KT to refer vulnerable patients to prehabilitation in hopes of reducing risk of adverse post-KT outcomes.
PMCID:8273213
PMID: 33449609
ISSN: 1534-6080
CID: 5126892
Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
Lai, Jennifer C; Ganger, Daniel R; Volk, Michael L; Dodge, Jennifer L; Dunn, Michael A; Duarte-Rojo, Andres; Kappus, Matthew R; Rahimi, Robert S; Ladner, Daniela P; Boyarsky, Brian; McAdams-DeMarco, Mara; Segev, Dorry L; McCulloch, Charles E; Verna, Elizabeth C
Importance:Female liver transplant candidates experience higher rates of wait list mortality than male candidates. Frailty is a critical determinant of mortality in patients with cirrhosis, but how frailty differs between women and men is unknown. Objective:To determine whether frailty is associated with the gap between women and men in mortality among patients with cirrhosis awaiting liver transplantation. Design, Setting, and Participants:This prospective cohort study enrolled 1405 adults with cirrhosis awaiting liver transplant without hepatocellular carcinoma seen during 3436 ambulatory clinic visits at 9 US liver transplant centers. Data were collected from January 1, 2012, to October 1, 2019, and analyzed from August 30, 2019, to October 30, 2020. Exposures:At outpatient evaluation, the Liver Frailty Index (LFI) score was calculated (grip strength, chair stands, and balance). Main Outcomes and Measures:The risk of wait list mortality was quantified using Cox proportional hazards regression by frailty. Mediation analysis was used to quantify the contribution of frailty to the gap in wait list mortality between women and men. Results:Of 1405 participants, 578 (41%) were women and 827 (59%) were men (median age, 58 [interquartile range (IQR), 50-63] years). Women and men had similar median scores on the laboratory-based Model for End-stage Liver Disease incorporating sodium levels (MELDNa) (women, 18 [IQR, 14-23]; men, 18 [IQR, 15-22]), but baseline LFI was higher in women (mean [SD], 4.12 [0.85] vs 4.00 [0.82]; P = .005). Women displayed worse balance of less than 30 seconds (145 [25%] vs 149 [18%]; P = .003), worse sex-adjusted grip (mean [SD], -0.31 [1.08] vs -0.16 [1.08] kg; P = .01), and fewer chair stands per second (median, 0.35 [IQR, 0.23-0.46] vs 0.37 [IQR, 0.25-0.49]; P = .04). In unadjusted mixed-effects models, LFI was 0.15 (95% CI, 0.06-0.23) units higher in women than men (P = .001). After adjustment for other variables associated with frailty, LFI was 0.16 (95% CI, 0.08-0.23) units higher in women than men (P < .001). In unadjusted regression, women experienced a 34% (95% CI, 3%-74%) increased risk of wait list mortality than men (P = .03). Sequential covariable adjustment did not alter the association between sex and wait list mortality; however, adjustment for LFI attenuated the mortality gap between women and men. In mediation analysis, an estimated 13.0% (IQR, 0.5%-132.0%) of the gender gap in wait list mortality was mediated by frailty. Conclusions and Relevance:These findings demonstrate that women with cirrhosis display worse frailty scores than men despite similar MELDNa scores. The higher risk of wait list mortality that women experienced appeared to be explained in part by frailty.
PMID: 33377947
ISSN: 2168-6262
CID: 5126882
Rising Cost of Thyroid Surgery in Adult Patients
Sahli, Zeyad T; Zhou, Sheng; Sharma, Ashwyn K; Segev, Dorry L; Massie, Allan; Zeiger, Martha A; Mathur, Aarti
BACKGROUND:The aim of this study is to describe the economic trends in adults who underwent elective thyroidectomy. METHODS:We performed a population-based study utilizing the Premier Healthcare Database to examine adult patients who underwent elective thyroidectomy between January 2006 and December 2014. Time was divided into three equal time periods (2006-2008, 2009-2011, and 2012-2014). To examine trend in patient charges, we modeled patient charges using generalized linear regressions adjusting for key covariates with standard errors clustered at the hospital level. RESULTS:Our study cohort consisted of 52,012 adult patients who underwent a thyroid operation. During the study period, the most common procedure changed from a thyroid lobectomy to bilateral thyroidectomy. Over the study period, there was an increase in the proportion of completion thyroidectomies from 1.1% to 1.6% (PÂ <Â 0.001), malignant diagnoses from 21.7% to 26.8% (PÂ <Â 0.001), procedures performed at teaching hospitals from 27.7% to 32.9% (PÂ <Â 0.001), and procedures performed on an outpatient basis from 93.85% to 97.55% (PÂ <Â 0.001). The annual increase in median patient charge adjusted for inflation was $895 or 4.3% resulting in an increase of 38.8% over 9Â y. Higher thyroidectomy charges were associated with male patients, malignant surgical pathology, patients undergoing limited or radical neck dissection, experiencing complications, those with managed health care insurance, and a prolonged length of stay. CONCLUSIONS:Despite recent changes in thyroid surgery practices to decrease the economic burden of hospitals, costs continue to rise 4.3% annually. Additional prospective studies are needed to identify factors associated with this increasing cost.
PMCID:7946711
PMID: 33316757
ISSN: 1095-8673
CID: 5126872
Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic
Bae, Sunjae; McAdams-DeMarco, Mara A; Massie, Allan B; Ahn, JiYoon B; Werbel, William A; Brennan, Daniel C; Lentine, Krista L; Durand, Christine M; Segev, Dorry L
BACKGROUND:Kidney transplant recipients have higher risk of infectious diseases due to their reliance on immunosuppression. During the current COVID-19 pandemic, some clinicians might have opted for less potent immunosuppressive agents to counterbalance the novel infectious risk. We conducted a nationwide study to characterize immunosuppression use and subsequent clinical outcomes during the first 5 months of COVID-19 pandemic in the United States. METHODS:Using data from the Scientific Registry of Transplant Recipients, we studied all kidney-only recipients in the United States from January 1, 2017, to March 12, 2020 ("prepandemic" era; n = 64 849) and from March 13, 2020, to July 31, 2020 ("pandemic" era; n = 5035). We compared the use of lymphocyte-depleting agents (versus basiliximab or no induction) and maintenance steroids (versus steroid avoidance/withdrawal) in the pandemic era compared with the prepandemic era. Then, we compared early posttransplant outcomes by immunosuppression regimen during the pandemic era. RESULTS:Recipients in the pandemic era were substantially less likely to receive lymphocyte-depleting induction agents compared with their prepandemic counterparts (aOR = 0.400.530.69); similar trends were found across subgroups of state-level COVID-19 incidence, donor type, and recipient age. However, lymphocyte-depleting induction agents were associated with decreased rejection during admission (aOR = 0.110.230.47) but not with increased mortality in the pandemic era (aHR = 0.130.471.66). On the other hand, the use of maintenance steroids versus early steroid withdrawal remained similar (aOR = 0.711.071.62). CONCLUSIONS:The use of lymphocyte-depleting induction agents has decreased in favor of basiliximab and no induction during the COVID-19 pandemic. However, this shift might have resulted in increases in rejection with no clear reductions in posttransplant mortality.
PMID: 33093404
ISSN: 1534-6080
CID: 5126762
Liver simulated allocation model does not effectively predict organ offer decisions for pediatric liver transplant candidates
Wood, Nicholas L; Mogul, Douglas B; Perito, Emily R; VanDerwerken, Douglas; Mazariegos, George V; Hsu, Evelyn K; Segev, Dorry L; Gentry, Sommer E
The SRTR maintains the liver-simulated allocation model (LSAM), a tool for estimating the impact of changes to liver allocation policy. Integral to LSAM is a model that predicts the decision to accept or decline a liver for transplant. LSAM implicitly assumes these decisions are made identically for adult and pediatric liver transplant (LT) candidates, which has not been previously validated. We applied LSAM's decision-making models to SRTR offer data from 2013 to 2016 to determine its efficacy for adult (≥18) and pediatric (<18) LT candidates, and pediatric subpopulations-teenagers (≥12 to <18), children (≥2 to <12), and infants (<2)-using the area under the receiver operating characteristic (ROC) curve (AUC). For nonstatus 1A candidates, all pediatric subgroups had higher rates of offer acceptance than adults. For non-1A candidates, LSAM's model performed substantially worse for pediatric candidates than adults (AUC 0.815 vs. 0.922); model performance decreased with age (AUC 0.898, 0.806, 0.783 for teenagers, children, and infants, respectively). For status 1A candidates, LSAM also performed worse for pediatric than adult candidates (AUC 0.711 vs. 0.779), especially for infants (AUC 0.618). To ensure pediatric candidates are not unpredictably or negatively impacted by allocation policy changes, we must explicitly account for pediatric-specific decision making in LSAM.
PMID: 33891805
ISSN: 1600-6143
CID: 5127152
Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
Charnaya, Olga; Chiang, Teresa Po-Yu; Wang, Richard; Motter, Jennifer D; Boyarsky, Brian J; King, Elizabeth A; Werbel, William A; Durand, Christine M; Avery, Robin K; Segev, Dorry L; Massie, Allan B; Garonzik-Wang, Jacqueline M
BACKGROUND:In March 2020, COVID-19 infections began to rise exponentially in the USA, placing substantial burden on the healthcare system. As a result, there was a rapid change in transplant practices and policies, with cessation of most procedures. Our goal was to understand changes to pediatric kidney transplantation (KT) at the national level during the COVID-19 epidemic. METHODS:Using SRTR data, we examined changes in pediatric waitlist registration, waitlist removal or inactivation, and deceased donor and living donor (DDKT/LDKT) events during the start of the disease transmission in the USA compared with the same time the previous year. RESULTS:) in states with high vs. low COVID activity. Transplant recipients during the pandemic were more likely to have received a DDKT, but had similar calculated panel-reactive antibody (cPRA) values, waitlist time, and cause of kidney failure as before the pandemic. CONCLUSIONS:The COVID-19 pandemic initially reduced access to kidney transplantation among pediatric patients in the USA but has not had a sustained effect.
PMID: 32980942
ISSN: 1432-198x
CID: 5126712
Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses
Strauss, Alexandra T; Boyarsky, Brian J; Garonzik-Wang, Jacqueline M; Werbel, William; Durand, Christine M; Avery, Robin K; Jackson, Kyle R; Kernodle, Amber B; Baker, Talia; Snyder, Jon; Segev, Dorry L; Massie, Allan B
COVID-19Â has profoundly affected the American health care system; its effect on the liver transplant (LT) waitlist based on COVID-19 incidence has not been characterized. Using SRTR data, we compared observed LT waitlist registrations, waitlist mortality, deceased donor LTs (DDLT), and living donor LTs (LDLT) 3/15/2020-8/31/2020 to expected values based on historical trends 1/2016-1/2020, stratified by statewide COVID-19 incidence. Overall, from 3/15 to 4/30, new listings were 11% fewer than expected (IRRÂ =Â 0.84 0.890.93 ), LDLTs were 49% fewer (IRRÂ =Â 0.37 0.510.72 ), and DDLTs were 9% fewer (IRRÂ =Â 0.85 0.910.97 ). In May, new listings were 21% fewer (IRRÂ =Â 0.74 0.790.84 ), LDLTs were 42% fewer (IRRÂ =Â 0.39 0.580.85 ) and DDLTs were 13% more (IRRÂ =Â 1.07 1.151.23 ). Centers in states with the highest incidence 3/15-4/30 had 59% more waitlist deaths (IRRÂ =Â 1.09 1.592.32 ) and 34% fewer DDLTs (IRRÂ =Â 0.50 0.660.86 ). By August, waitlist outcomes were occurring at expected rates, except for DDLT (13% more across all incidences). While the early COVID-affected states endured major transplant practice changes, later in the pandemic the newly COVID-affected areas were not impacted to the same extent. These results speak to the adaptability of the transplant community in addressing the pandemic and applying new knowledge to patient care.
PMID: 33107180
ISSN: 1600-6143
CID: 5126772